HUTCHMED (China) Ltd H7T2
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- €2.34
- Day Range
- €2.32–2.32
- 52-Week Range
- —–—
- Bid/Ask
- €2.30 / €2.62
- Shares Outstanding
- 869.07M
- Market Cap
- €2.02B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 4.80
- Price/Sales
- 4.34
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,796
- Website
- https://www.hutch-med.com
Valuation
|
Metric
|
H7T2
|
|---|---|
Price/Earnings (Normalized) | 4.80 |
Price/Book Value | 1.84 |
Price/Sales | 4.34 |
Price/Cash Flow | 40.81 |
Price/Earnings
H7T2
Financial Strength
|
Metric
|
H7T2
|
|---|---|
Quick Ratio | 5.45 |
Current Ratio | 5.64 |
Interest Coverage | — |
Quick Ratio
H7T2
Profitability
|
Metric
|
H7T2
|
|---|---|
Return on Assets (Normalized) | 2.11% |
Return on Equity (Normalized) | 2.98% |
Return on Invested Capital (Normalized) | 2.74% |
Return on Assets
H7T2
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|lFW&%Bs | LOCK|fhT<s | $71B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|QH$p<s> | LOCK|%Qbp< | $49B | |||
| Haleon PLC ADR
HLN
| LOCK|%zN&^Q | LOCK|%< | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|ch^&pj? | LOCK|jf | $32B | |||
| Viatris Inc
VTRS
| LOCK|^#$wMD | LOCK|H% | $22B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|!H?bCL | LOCK|k#@ | $12B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|^f | LOCK|VK< | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|q$r%d?? | LOCK|$B | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|T@RzxY | LOCK|?!Sn | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|fkLB<$ | LOCK|!qp | $2B |
United States